RxCap Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$19.7M
- Investors
-
1
RxCap General Information
Description
Developer of patient management platform designed to empower healthcare enterprises to support their patients and members in staying adherent to their medications. The company's platform offers medical devices such as smart caps, smartwatches, pulse oxymeters, blood pressure monitors, and inhalers, enabling healthcare corporations to deliver better patient outcomes through medical prescription compliance and adherence products.
Contact Information
Website
www.rxcap.comCorporate Office
- Boston, MA 01940
- United States
Corporate Office
- Boston, MA 01940
- United States
RxCap Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 06-May-2024 | $19.7M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | Completed | Startup |
RxCap Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | 3,469,410 | $0.000010 | $3.46 | $3.46 | 1x | $3.46 | 6.58% | |
| Series A | 12,684,744 | $0.000010 | $0.45 | $0.45 | 1x | $0.45 | 27.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RxCap Patents
RxCap Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260199189-A1 | Medication organizer with smart features | Pending | 31-Dec-2024 | ||
| WO-2026148163-A1 | Medication organizer with smart features | Pending | 31-Dec-2024 | ||
| US-20260184480-A1 | Screw top smart cap | Pending | 31-Dec-2024 | ||
| WO-2026148165-A1 | Screw top smart cap | Pending | 31-Dec-2024 | ||
| US-20260183497-A1 | Smart inhaler device for medication adherence | Pending | 31-Dec-2024 | A61M15/009 |
RxCap Signals
RxCap Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gerresheimer | Corporation | Minority |
RxCap FAQs
-
When was RxCap founded?
RxCap was founded in 2019.
-
Where is RxCap headquartered?
RxCap is headquartered in Boston, MA.
-
What is the size of RxCap?
RxCap has 15 total employees.
-
What industry is RxCap in?
RxCap’s primary industry is Monitoring Equipment.
-
Is RxCap a private or public company?
RxCap is a Private company.
-
What is the current valuation of RxCap?
The current valuation of RxCap is .
-
What is RxCap’s current revenue?
The current revenue for RxCap is .
-
How much funding has RxCap raised over time?
RxCap has raised $25.4M.
-
Who are RxCap’s investors?
Gerresheimer has invested in RxCap.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process